Evidence map›Paper›PMID 38164023›Full record

ReviewThe world journal of men's health2024

Advances in Male Contraception: When Will the Novel Male Contraception be Available?

Jongwon Kim, Byeongchan So, Yongki Heo, Hongyun So, Jung Ki Jo

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in The world journal of men's health, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Jongwon KimDepartment of Medical and Digital Engineering, Hanyang University, Seoul, Korea.ORCID https://orcid.org/0000-0002-2579-9344
Byeongchan SoDepartment of Medical and Digital Engineering, Hanyang University, Seoul, Korea.ORCID https://orcid.org/0000-0002-8523-8012
Yongki HeoDepartment of Medical and Digital Engineering, Hanyang University, Seoul, Korea.ORCID https://orcid.org/0000-0001-9945-3613
Hongyun SoDepartment of Medical and Digital Engineering, Hanyang University, Seoul, Korea.ORCID https://orcid.org/0000-0003-3870-388X
Jung Ki JoDepartment of Medical and Digital Engineering, Hanyang University, Seoul, Korea.ORCID https://orcid.org/0000-0002-6080-7493

Funding

Korea Evaluation Institute of Industrial Technology RS-2023-00256247National Research Foundation of Korea NRF-2021R1C1C1010836
6 · The paper itself

Abstract

Many contraceptive methods have been developed over the years due to high demand. However, female contraceptive pills and devices do not work for all females due to health conditions and side effects. Also, the number of males who want to actively participate in family planning is gradually increasing. However, the only contraceptive options currently available to males are condoms and vasectomy. Therefore, many male contraceptive methods, including medication (hormonal and non-hormonal therapy) and mechanical methods, are under development. Reversibility, safety, persistence, degree of invasion, promptness, and the suppression of anti-sperm antibody formation are essential factors in the development of male contraceptive methods. In this paper, male contraceptive methods under development are reviewed according to those essential factors. Furthermore, the timeline for the availability of a new male contraception is discussed.

Indexed as

AzoospermiaContraceptionContraceptive agentsDrug developmentSpermatogenesisSterilization

Identifiers

PMID38164023
PMCPMC11216971

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.